Moderna begins phase-3 clinical trial of COVID vaccine in US
New York: Pharmaceutical company Moderna has begun a phase-3 clinical trial to evaluate an investigational vaccine known as mRNA-1273 designed to protect against the Covid-19 virus.
The trial, which will be conducted at the US clinical…